PLYMOUTH, Minn. & WASHINGTON--(BUSINESS WIRE)--Lumen Biomedical, Inc., a Minnesota-based medical device company, announced today that Co-Principal Investigator Subbarao V. Myla, M.D. will present the results from the EPIC clinical trial: Evaluating the Use of the FiberNet® Embolic Protection Device in Carotid Artery Stenting, during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, at the Washington Convention Center in Washington DC. The presentation is scheduled for Thursday, October 16, 2008 at 1 p.m. as part of “The Late Breaking First Report Investigations” taking place in the Main Arena. The press conference will also take place on October 16 from 9:50-10:00 a.m. in room 159A.
